In the aspect of interpretation of our findings in context of T2DM patients, it is important to mention, that cells expressing CD56 antigen are considered to be activated cells exhibiting some level of cytotoxic properties, therefore, possibly sharing similar properties. This evidence concerns the gene NCAM1 and type 2 diabetes mellitus.